Efficacy of Reduced-Intensity Allogeneic Stem Cell Transplantation in Chemotherapy-Refractory Non-Hodgkin Lymphoma

Robert M. Dean; Daniel H. Fowler; Wyndham H. Wilson; Jeanne Odom; Seth M. Steinberg; Catherine Chow; Claude Kasten-Sportes; Ronald E. Gress; Michael R. Bishop

doi:10.1016/j.bbmt.2005.04.005

Efficacy of Reduced-Intensity Allogeneic Stem Cell Transplantation in Chemotherapy-Refractory Non-Hodgkin Lymphoma

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2005.04.005 ◽

2005 ◽

Vol 11 (8) ◽

pp. 593-599 ◽

Cited By ~ 25

Author(s):

Robert M. Dean ◽

Daniel H. Fowler ◽

Wyndham H. Wilson ◽

Jeanne Odom ◽

Seth M. Steinberg ◽

...

Keyword(s):

Stem Cell ◽

Stem Cell Transplantation ◽

Hodgkin Lymphoma ◽

Cell Transplantation ◽

Allogeneic Stem Cell Transplantation ◽

Non Hodgkin Lymphoma ◽

Reduced Intensity

Download Full-text

Sequential Myeloablative Autologous Stem Cell Transplantation and Reduced Intensity Allogeneic Stem Cell Transplantation in Children, Adolescents and Young Adults with Poor Risk Refractory or Recurrent Hodgkin (HL) and Non-Hodgkin Lymphoma (NHL)

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2013.12.107 ◽

2014 ◽

Vol 20 (2) ◽

pp. S85 ◽

Cited By ~ 1

Author(s):

Prakash Satwani ◽

Zhezhen Jin ◽

Monica Bhatia ◽

James Garvin ◽

Diane George ◽

...

Keyword(s):

Young Adults ◽

Stem Cell ◽

Stem Cell Transplantation ◽

Hodgkin Lymphoma ◽

Cell Transplantation ◽

Autologous Stem Cell Transplantation ◽

Allogeneic Stem Cell Transplantation ◽

Adolescents And Young Adults ◽

Non Hodgkin Lymphoma ◽

Reduced Intensity

Download Full-text

Sustained response after reduced-intensity conditioning allogeneic stem cell transplantation for patients with relapsed peripheral T-cell non-Hodgkin lymphoma

British Journal of Haematology ◽

10.1111/j.1365-2141.2008.07212.x ◽

2008 ◽

Vol 142 (5) ◽

pp. 848-850 ◽

Cited By ~ 5

Author(s):

Hugues de Lavallade ◽

Philippe A. Cassier ◽

Reda Bouabdallah ◽

Jean El-Cheikh ◽

Catherine Faucher ◽

...

Keyword(s):

Stem Cell ◽

T Cell ◽

Stem Cell Transplantation ◽

Hodgkin Lymphoma ◽

Cell Transplantation ◽

Allogeneic Stem Cell Transplantation ◽

Sustained Response ◽

Reduced Intensity Conditioning ◽

Non Hodgkin Lymphoma ◽

Reduced Intensity

Download Full-text

Gemcitabine, Fludarabine, and Melphalan for Reduced-Intensity Conditioning and Allogeneic Stem Cell Transplantation for Relapsed and Refractory Hodgkin Lymphoma

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2016.03.028 ◽

2016 ◽

Vol 22 (7) ◽

pp. 1333-1337 ◽

Cited By ~ 16

Author(s):

Paolo Anderlini ◽

Rima M. Saliba ◽

Celina Ledesma ◽

Tamera Plair ◽

Amin M. Alousi ◽

...

Keyword(s):

Stem Cell ◽

Stem Cell Transplantation ◽

Hodgkin Lymphoma ◽

Cell Transplantation ◽

Allogeneic Stem Cell Transplantation ◽

Reduced Intensity Conditioning ◽

Refractory Hodgkin Lymphoma ◽

Reduced Intensity

Download Full-text

Sequential myeloablative autologous stem cell transplantation and reduced intensity allogeneic hematopoietic cell transplantation is safe and feasible in children, adolescents and young adults with poor-risk refractory or recurrent Hodgkin and non-Hodgkin lymphoma

Leukemia ◽

10.1038/leu.2014.194 ◽

2014 ◽

Vol 29 (2) ◽

pp. 448-455 ◽

Cited By ~ 28

Author(s):

P Satwani ◽

Z Jin ◽

P L Martin ◽

M Bhatia ◽

J H Garvin ◽

...

Keyword(s):

Young Adults ◽

Stem Cell ◽

Stem Cell Transplantation ◽

Hodgkin Lymphoma ◽

Cell Transplantation ◽

Autologous Stem Cell Transplantation ◽

Hematopoietic Cell Transplantation ◽

Hematopoietic Cell ◽

Non Hodgkin Lymphoma ◽

Reduced Intensity

Download Full-text

Outcomes of Patients 65 Years and Older with Non-Hodgkin Lymphoma Receiving Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation Compared to Patients 55-64 Years of Age: A CIBMTR Analysis

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2017.12.661 ◽

2018 ◽

Vol 24 (3) ◽

pp. S77-S78

Author(s):

Nirav Shah ◽

Kwang Woo Ahn ◽

Carlos Litovich ◽

Anna Sureda ◽

Sonali M. Smith ◽

...

Keyword(s):

Stem Cell ◽

Hematopoietic Stem Cell Transplantation ◽

Stem Cell Transplantation ◽

Hodgkin Lymphoma ◽

Cell Transplantation ◽

Hematopoietic Stem Cell ◽

Reduced Intensity Conditioning ◽

Hematopoietic Stem ◽

Non Hodgkin Lymphoma ◽

Reduced Intensity

Download Full-text

Assessment of the Hematopoietic Cell Transplantation Comorbidity Index in Non-Hodgkin Lymphoma Patients Receiving Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2008.11.023 ◽

2009 ◽

Vol 15 (2) ◽

pp. 223-230 ◽

Cited By ~ 32

Author(s):

Seth M. Pollack ◽

Seth M. Steinberg ◽

Jeanne Odom ◽

Robert M. Dean ◽

Daniel H. Fowler ◽

...

Keyword(s):

Stem Cell ◽

Hematopoietic Stem Cell Transplantation ◽

Stem Cell Transplantation ◽

Hodgkin Lymphoma ◽

Cell Transplantation ◽

Hematopoietic Cell Transplantation ◽

Hematopoietic Stem ◽

Non Hodgkin Lymphoma ◽

Comorbidity Index ◽

Reduced Intensity

Download Full-text

Outcomes after Allogeneic Stem Cell Transplantation for Patients with Non-Hodgkin Lymphoma: Texas Children's Hospital Experience 1999-2013

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2014.11.323 ◽

2015 ◽

Vol 21 (2) ◽

pp. S211-S212

Author(s):

Swati Naik ◽

Paul Castillo ◽

Caridad Martinez ◽

Kathryn Leung ◽

Ghadir Sasa ◽

...

Keyword(s):

Stem Cell ◽

Stem Cell Transplantation ◽

Hodgkin Lymphoma ◽

Cell Transplantation ◽

Allogeneic Stem Cell Transplantation ◽

Children's Hospital ◽

Non Hodgkin Lymphoma ◽

Hospital Experience ◽

Children’S Hospital

Download Full-text

High Response Rate to Donor Lymphocyte Infusion after Allogeneic Stem Cell Transplantation for Indolent Non-Hodgkin Lymphoma

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2007.04.013 ◽

2008 ◽

Vol 14 (1) ◽

pp. 50-58 ◽

Cited By ~ 80

Author(s):

Adrian J.C. Bloor ◽

Kirsty Thomson ◽

Noha Chowdhry ◽

Stephanie Verfuerth ◽

Stuart J. Ings ◽

...

Keyword(s):

Stem Cell ◽

Stem Cell Transplantation ◽

Hodgkin Lymphoma ◽

Cell Transplantation ◽

Allogeneic Stem Cell Transplantation ◽

Response Rate ◽

Donor Lymphocyte Infusion ◽

High Response Rate ◽

High Response ◽

Non Hodgkin Lymphoma

Download Full-text

Carmustine, Etoposide, Cytarabine, and Melphalan (BEAM)–Campath Allogeneic Stem Cell Transplantation for Aggressive Non-Hodgkin Lymphoma: An Analysis of Outcomes from the British Society of Blood and Marrow Transplantation

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2014.11.673 ◽

2015 ◽

Vol 21 (3) ◽

pp. 483-488 ◽

Cited By ~ 4

Author(s):

Edward Truelove ◽

Christopher Fox ◽

Stephen Robinson ◽

Rachael Pearce ◽

Julia Perry ◽

...

Keyword(s):

Stem Cell ◽

Stem Cell Transplantation ◽

Hodgkin Lymphoma ◽

Cell Transplantation ◽

Allogeneic Stem Cell Transplantation ◽

Marrow Transplantation ◽

British Society ◽

Blood And Marrow Transplantation ◽

Non Hodgkin Lymphoma

Download Full-text

S1622 TANDEM AUTOLOGOUS-REDUCED INTENSITY ALLOGENEIC STEM CELL TRANSPLANTATION IN HIGH-RISK RELAPSED HODGKIN LYMPHOMA: A RETROSPECTIVE STUDY OF THE LWP-EBMT

HemaSphere ◽

10.1097/01.hs9.0000564736.59814.ec ◽

2019 ◽

Vol 3 (S1) ◽

pp. 749-750 ◽

Cited By ~ 1

Author(s):

L. Bento ◽

A. Boumendil ◽

H. Fine ◽

I. Khvedelidze ◽

D. Blaise ◽

...

Keyword(s):

Stem Cell ◽

Retrospective Study ◽

High Risk ◽

Stem Cell Transplantation ◽

Hodgkin Lymphoma ◽

Cell Transplantation ◽

Allogeneic Stem Cell Transplantation ◽

Reduced Intensity

Download Full-text